Form 8-K - Current report:
SEC Accession No. 0001564590-19-046547
Filing Date
2019-12-20
Accepted
2019-12-20 16:06:34
Documents
14
Period of Report
2019-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-8k_20191219.htm   iXBRL 8-K 37155
2 EX-10.1 hrtx-ex101_6.htm EX-10.1 119693
3 GRAPHIC grpviqp5tbbz000001.jpg GRAPHIC 40735
  Complete submission text file 0001564590-19-046547.txt   362516

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20191219.xsd EX-101.SCH 5964
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20191219_lab.xml EX-101.LAB 19480
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20191219_pre.xml EX-101.PRE 11629
16 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-8k_20191219_htm.xml XML 3568
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 191301368
SIC: 2834 Pharmaceutical Preparations